Cannabis & Hemp Extraction: Process selection and regulation
Speaking in December 2019, Dr. Graham Wood and Jenna Agin from Neptune Wellness Solutions explored cannabis & hemp extraction.
Toward a Comprehensive Multi-Omic Analysis of Cannabis Plants
Ben Orsburn P.h.D., Chief Scientific Officer at Think20Labs discusses the progress made toward a comprehensive cannabis muti-omic analysis and in-house work to complete the genome resources currently available.
The safety of vaping: Facts, misconceptions and fiction
In November 2019, we were pleased to be joined by Dr. Graham Wood, Chief Scientific Officer of Neptune Wellness Solutions to explore the safety of vaping.
High Throughput Automated LC/MS Pesticide Analysis: From Cannabis Sample Prep & Dilutions to Report Generation
Toby Astill P.H.D., from PerkinElmer discusses a brand-new analytical and software workflow solution for faster cannabis testing turnaround times.
Practical Analytical Considerations for Cannabis Producers and Processors
Taylor Trah, Formulation Director at OutCo discusses the pros and cons of in-house testing within their extraction facility, including the approaches considered and final decision.
Getting Down in the Weeds: A brief overview of the technical and regulatory landscape of pesticide residue analysis for cannabis and derivative products
Rebecca Stevens, Analytical Chemist from ProVerde Labs discusses pesticide residue analysis and the regulatory landscape.
Cannabis Extraction Considerations: An Overview of the Complexities of Production
Ryan Pincura from ZenLabs discusses the main considerations in cannabis extraction, such as final product, winterization, and reformulation.
Variability in Cannabis Testing: Inter-laboratory discrepancies in test results
Speaking in 2019 at the Analytical Cannabis Expo, Dr. Chris Hudalla, Founder & Chief Scientific Officer at ProVerde Laboratories discusses the challenges in analytical cannabis testing and strategies to minimize these factors.
Using Cryptocurrencies and Blockchain Technologies to Fund the De Novo Sequencing, Assembly, and Open Access Publishing of the Cannabis sativa L. Genome
Speaking in 2019 at the Analytical Cannabis Expo, Kevin McKernan, CSO & Founder of Medicinal Genomics discusses how they sequenced and assembled a comprehensive cannabis genome as a demonstrative model for a blockchain recorded peer review.
